T2	Participants 463 512	In 32 patients with newly diagnosed untreated AML
T3	Participants 529 581	immunohistochemical analysis of bone marrow biopsies
T4	Participants 649 668	10 control patients
T1	Participants 122 158	patients with acute myeloid leukemia
